Annotated Medicine and Device Lists


Neostigmine

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 15.1.7 Anticholinesterases Others observations:
methylsulphate
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 12:04 Cholinergic Agents No observations
Barbados. Barbados National Drug Formulary (BNDF) 12.04 Parasympathetic (Cholinergic) Agents No observations
Belize. National Drug Formulary 01.04 Muscle relaxants and cholinesterase inhibitors No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 10.02.01 Drugs that enhance neuromuscular transmission (Anticholinesterases) No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 15.01.06 Anticholinesterases Used in Surgery No observations

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 06.04. Anaesthetic Adjuncts and Adjuvants No observations

This medicine is present in:

List Section Observation
Guyana. Essential Medicines List. 2020-2021 2.01. Cholinesterase inhibitors No observations

This medicine is present in:

List Section Observation
Peru 20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. No observations
Suriname. NGK-C-011 20. Muscle Relaxants and Cholinesterase Inhibitors No observations
Haiti. National List of Essential Medicines 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS No observations
Ecuador Essential Medicines List - Ecuador No observations
Belize. National Drug Formulary 20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS No observations
Belize. National Drug Formulary 01.04 Muscle relaxants and cholinesterase inhibitors No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Autonomic Cholinergic No observations
Haiti. National List of Essential Medicines 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors No observations
Bahamas. Drug Formulary 20.1 Cholinergic and Anticholinesterase Agents No observations
Bahamas. Drug Formulary 06.04. Anaesthetic Adjuncts and Adjuvants No observations
Belize. National Drug Formulary 20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 22. Colinérgicos Others observations:
Como metilsulfato.
Mexico. Cuadro Basico de Medicamentos - 2017 02. ANESTESIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 11. INTOXICACIONES No observations
Mexico. Cuadro Basico de Medicamentos - 2017 02. ANESTESIA No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 07. OTRAS DROGAS QUE ACTÚAN SOBRE EL SISTEMA NERVIOSO No observations
El Salvador - 2019 Otras DROGAS QUE AFECTAN EL SISTEMA NERVIOSO No observations
Chile. Formulario Nacional de Medicamentos. 2005 01.04. RELAJANTES MUSCULARES No observations
Chile. Formulario Nacional de Medicamentos. 2005 16.07. OTROS No observations
Bahamas. Drug Formulary 20.1 Cholinergic and Anticholinesterase Agents No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
metilsulphate INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 17.02. ANTICOLINESTERÁSICOS Y FÁRMACOS PARA DIAGNÓSTICO Y TRATAMIENTO DE LA MIASTENIA GRAVIS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS No observations
Peru 20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
EST. X 2 BLISTER X 10 TABLETAS C/U.
Costa Rica. Caja Costarricense de Seguro Social. 2019 22. Colinérgicos No observations
Mexico. Cuadro Basico de Medicamentos - 2017 02. ANESTESIA No observations
Chile. Formulario Nacional de Medicamentos. 2005 16.07. OTROS No observations
Haiti. National List of Essential Medicines 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors No observations
Barbados. Barbados National Drug Formulary (BNDF) 12.04 Parasympathetic (Cholinergic) Agents No observations
Bahamas. Drug Formulary 20.1 Cholinergic and Anticholinesterase Agents No observations
Belize. National Drug Formulary 20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS No observations

Information Resources: Neostigmine

Loading ...
Loading ...
Loading ...
No information available